CJC-1295 No DAC + Ipamorelin 10mg
≥99.0%
Third-Party
COA
Complete your research kit
Third-Party Tested
HPLC & mass spec verified purity
Batch Specific COA
Certificate with every batch
Discreet Packaging
Plain, unbranded, tamper-evident
Same-Day Dispatch
Before 2PM AEST, Australia-wide
CJC-1295 (no DAC) + Ipamorelin is a pre-blended research peptide formulation developed for laboratory investigation of growth hormone (GH) signalling through two distinct receptor pathways. CJC-1295 (no DAC) acts through the growth hormone-releasing hormone receptor (GHRH-R), while Ipamorelin interacts with the growth hormone secretagogue receptor, GHS-R1a. This complementary activity makes the blend relevant to experimental endocrine and peptide-signalling research. CJC-1295 (no DAC) + Ipamorelin Australia products are intended exclusively for controlled laboratory and scientific research.
What Is CJC-1295 (No DAC) + Ipamorelin?
CJC-1295 (no DAC), sometimes described in research literature as Modified GRF (1-29), is a synthetic analogue associated with GHRH-receptor signalling. Unlike CJC-1295 containing a Drug Affinity Complex (DAC), the no-DAC form does not incorporate the albumin-binding modification designed to prolong systemic persistence.
Ipamorelin belongs to the growth hormone secretagogue class of peptides. Its experimental activity is primarily associated with GHS-R1a, commonly known as the ghrelin receptor. Activation of this receptor represents a signalling route distinct from the GHRH pathway.
Combining the peptides therefore gives researchers a single preparation in which two receptor systems associated with GH release can be examined together.
Key Research Areas
CJC-1295 (no DAC) + Ipamorelin research is primarily associated with endocrine signalling. Experimental work involving these peptides has examined:
These areas describe experimental research interests rather than established therapeutic effects. Findings from preclinical or laboratory models should not be interpreted as evidence of benefits in humans.
Why Researchers Study CJC-1295 (No DAC) + Ipamorelin
The principal scientific interest in this combination comes from its two-pathway design. CJC-1295 (no DAC) is investigated for signalling through GHRH receptors, whereas Ipamorelin provides a separate experimental stimulus through GHS-R1a.
Researchers can consequently investigate how these receptor pathways behave when examined simultaneously rather than studying each peptide independently. Their complementary receptor activity has made the combination an area of interest in experimental GH-signalling research. This mechanistic rationale should not, however, be interpreted as proof that the blend produces superior biological or clinical outcomes.
Key Research Areas at a Glance
CJC-1295 (No DAC) + Ipamorelin in Australia
Researchers considering CJC-1295 (no DAC) + Ipamorelin Australia should evaluate the product according to analytical documentation, declared composition, batch identification and supplier information.
Before ordering CJC-1295 (no DAC) + Ipamorelin online, laboratories should confirm the current vial specification, price, stock status and Australian shipping information directly on the relevant product listing. Batch-specific CoA documentation should also be reviewed when available.
Specifications
Certificate of Analysis
Quality, Purity and Batch Testing
For laboratory research, peptide identity, composition and analytical documentation are important considerations, particularly for pre-blended formulations. Researchers should review the batch-specific Certificate of Analysis supplied with the product where available.
Analytical documentation may report peptide identity, measured content, purity and methods such as HPLC or mass spectrometry. For a blend, researchers should also check the measured quantity of each constituent rather than relying solely on the nominal total vial strength.
Analytical purity confirms characteristics of the tested sample; it does not demonstrate clinical safety, suitability or therapeutic effectiveness.
Storage & Handling
Storage and Laboratory Handling
- Lyophilised Storage: Follow the storage conditions stated on the product label and applicable batch documentation.
- After Reconstitution: Where validated post-reconstitution stability information is not supplied, researchers should follow their established laboratory protocol and batch documentation.
The material should be handled using appropriate laboratory procedures. Unsupported storage temperatures, stability periods, solvents or reconstitution volumes should not be assumed.
Reconstitution calculator: CJC-1295 No DAC + Ipamorelin 10mg
Work out concentration and the volume to draw for each aliquot before you add diluent.
- Concentration
- –
- Volume per aliquot
- –
- On a 1 mL (U-100) syringe
- –
- Aliquots per vial
- –
A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.
CJC-1295 No DAC + Ipamorelin 10mg: Frequently Asked Questions
It is a pre-blended research formulation combining two synthetic peptides associated with different receptor pathways involved in experimental GH signalling.
CJC-1295 (no DAC) is associated with GHRH-receptor signalling, while Ipamorelin acts primarily through the ghrelin receptor, GHS-R1a.
Researchers study them together because their distinct receptor interactions allow investigation of complementary endocrine signalling pathways within the same experimental model.
Research interests include GH signalling, GHRH and GHS-R1a receptor activity, IGF-1 pathways, pituitary signalling and related metabolic mechanisms.
Researchers should consult the applicable batch CoA for verified purity, identity, composition and analytical testing information.
Where provided by the supplier, a batch-specific CoA allows researchers to review analytical information relevant to the particular product batch.
Storage should follow the product label and verified batch documentation. After reconstitution, laboratories should use validated internal protocols where specific stability data are unavailable.
Availability, current price, stock status and domestic Australian shipping should be confirmed directly with the research peptide supplier before ordering.
No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.
Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.
Reviews
There are no reviews yet.